Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: A historical prospective cohort study

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Smith, Eric G ^a,b   Austin, Karen L ^a   Kim, Myra ^a,c   Miller, Donald R ^a,d   Eisen, Susan V ^a,d   Christiansen, Cindy L ^a,d   Kilbourne, Amy M ^a,e,f   Sauer, Brian C ^e,g   McCarthy, John F ^a,f   Valenstein, Marcia ^a,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Discontinuation; Intent to treat; Lithium; Matching; Propensity score; Suicidal behavior; Suicide; Valproate; Veterans; Veterans Health Administration

Indexed keywords

LITHIUM; VALPROIC ACID; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREVALENCE; PROPENSITY SCORE; RISK ASSESSMENT; RISK REDUCTION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; VETERANS HEALTH; COHORT ANALYSIS; GOVERNMENT; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGY; RISK; STATISTICS AND NUMERICAL DATA; UNITED STATES; VETERAN;

ANTIMANIC AGENTS; COHORT STUDIES; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SUICIDE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VALPROIC ACID; VETERANS; VETERANS HEALTH;

EID: 84924190640     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0357-x     Document Type: Article

References (59)

1. World Health Organization: Preventing suicide, a global imperative. Geneva, Switzerland: World Health Organzation; 2014. [ http://apps.who.int/iris/bitstream/10665/131056/1/9789241564779_eng.pdf?ua=1 ]
2. Boehmer TK, Flanders WD, McGeehin MA, Boyle C, Barrett DH: Postservice mortality in Vietnam veterans: 30-year follow-up. Arch Intern Med 2004, 164(17):1908-1916.
3. Ilgen MA, McCarthy JF, Ignacio RV, Bohnert AS, Valenstein M, Blow FC, Katz IR: Psychopathology, Iraq and Afghanistan Service, and Suicide Among Veterans Health Administration Patients. J Consult Clin Psychol 2012, 80(3):323-30.
4. Blow FC, Bohnert AS, Ilgen MA, Ignacio R, McCarthy JF, Valenstein MM, Knox KL: Suicide mortality among patients treated by the Veterans Health Administration from 2000 to 2007. Am J Public Health 2012, 102(Suppl 1):S98-104.
5. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J: Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006, 8(5 Pt 2):625-639.
6. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003, 290(11):1467-1473.
7. Baldessarini RJ, Tondo L: Lithium and suicidal risk. Bipolar Disord 2008, 10(1):114-115.
8. Cipriani A, Hawton K, Stockton S, Geddes JR: Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013, 346:f3646.
9. Lauterbach E, Felber W, Muller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, Kilb B, Lewitzka U, Hawellek B, Quante A, Richter K, Broocks A, Hohagen F: Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 2008, 118(6):469-479.
10. Ernst CL, Goldberg JF: Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry 2004, 12(1):14-41.
11. Nilsson A: Lithium therapy and suicide risk. J Clin Psychiatry 1999, 60(Suppl 2):85-88. discussion 111-116.
12. Baldessarini RJ, Tondo L, Hennen J: Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999, 60(Suppl 2):77-84. discussion 111-116.
13. Tondo L, Jamison KR, Baldessarini RJ: Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci 1997, 836:339-351.
14. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002, 159(4 Suppl 4):1-50.
15. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007, 26(4):734-753.
16. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA: High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 2009, 20(4):512-522.
17. Hernan MA, Robins JM: Authors' response, part I: observational studies analyzed like randomized experiments: best of both worlds. Epidemiology 2008, 19(6):789-792.
18. Blow FC, Valenstein M, Austin K, Khanuja K, McCarthy JF: Specialty Care for Veterans with Depression in the VHA: 2002 National Depression Registry Report. In. Ann Arbor, MI: VA National Serious Mental Illness Treatment Research & Evaluation Center (SMITREC), VHA Health Services Research & Development; 2003.
19. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ: Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007, 68(3):380-383.
20. Cowper DC, Kubal JD, Maynard C, Hynes DM: A primer and comparative review of major US mortality databases. Ann Epidemiol 2002, 12(7):462-468.
21. McCarthy JF, Valenstein M, Kim HM, Ilgen M, Zivin K, Blow FC: Suicide mortality among patients receiving care in the veterans health administration health system. Am J Epidemiol 2009, 169(8):1033-1038.
22. Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S: Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010, 303(14):1401-1409.
23. Bhattacharya J, Vogt W: Do instrumental variables belong in propensity scores? In NBER Technical Working Paper no 343. Cambridge, MA: National Bureau of Economic Research; 2007 [ http://www.nber.org/papers/t0343 ].
24. Wooldridge J: Should instrumental variables be used as matching variables? East Lansing, MI: Michigan State University; 2009 [ http://econ.msu.edu/faculty/wooldridge/docs/treat1r6.pdf ].
25. Pearl J: Invited commentary: understanding bias amplification. Am J Epidemiol 2011, 174(11):1223-1227. discussion pg 1228-1229.
26. Brooks JM, Ohsfeldt RL: Squeezing the balloon: propensity scores and unmeasured covariate balance. Health Serv Res 2013, 48(4):1487-501.
27. Austin PC: Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J 2009, 51(1):171-184.
28. Faries DE, Leon AC, Haro JM, Obenchain RL: Analysis of Observational Health Care Data Using SAS. Cary, NC: SAS Institute; 2010.
29. Cipriani A, Pretty H, Hawton K, Geddes JR: Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005, 162(10):1805-1819.
30. Ahrens B, Muller-Oerlinghausen B, Grof P: Length of lithium treatment needed to eliminate the high mortality of affective disorders. Br J Psychiatry Suppl 1993, 21:27-29.
31. Ahrens B, Grof P, Moller HJ, Muller-Oerlinghausen B, Wolf T: Extended survival of patients on long-term lithium treatment. Can J Psychiatry 1995, 40(5):241-246.
32. Muller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R: Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients. Acta Psychiatr Scand 1994, 90(4):295-297.
33. Muller-Oerlinghausen B, Muser-Causemann B, Volk J: Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992, 25(4):261-269.
34. Yerevanian BI, Ralph JK, Mintz J: Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J Affect Disord 2007, 103:5-11.
35. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA: ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011, 365(20):1896-1904.
36. Yerevanian BI, Koek RJ, Mintz J: Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J Affect Disord 2003, 73(3):223-228.
37. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS: Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants. J Affect Disord 2007, 103(1-3):13-21.
38. Yerevanian BI, Koek RJ, Mintz J: Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics. J Affect Disord 2007, 103(1-3):23-28.
39. Patrick AR, Miller M, Barber CW, Wang PS, Canning CF, Schneeweiss S: Identification of hospitalizations for intentional self-harm when E-codes are incompletely recorded. Pharmacoepidemiol Drug Saf 2010, 19(12):1263-1275.
40. Hammond KW, Laundry RJ, O'Leary TM, Jones WP: Use of text search to effectively identify lifetime prevalence of suicide attempts among veterans. Proceedings Of The 2013 46th Annual Hawaii International Conference On System Sciences (HICSS 2013), Jan 7-10, 2013, Computer Society Press, 2013, pp. 2676-2683 (ISBN: 978-1-4673-5933-7); available at http://www.computer.org/csdl/proceedings/hicss/2013/4892/00/4892c676.pdf
41. Kim H, Smith E, Stano C, Ganoczy D, Zivin K, Walters H, Valenstein M: Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res 2012, 12(1):18.
42. Miller M, Swanson SA, Azrael D, Pate V, Sturmer T: Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med 2014, 174(6):899-909.
43. Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ: Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol 2011, 174(11):1213-1222.
44. Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997, 170:205-228.
45. Koek RJ, Yerevanian BI, Mintz J: Subtypes of antipsychotics and suicidal behavior in bipolar disorder. J Affect Disord 2012, 143(1-3):27-33.
46. Sondergard L, Lopez AG, Andersen PK, Kessing LV: Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008, 10(1):87-94.
47. Smith EG, Sondergard L, Lopez AG, Andersen PK, Kessing LV: Association between consistent purchase of anticonvulsants or lithium and suicide risk: A longitudinal cohort study from Denmark, 1995-2001. J Affect Disord 2009, 117(3):162-7.
48. Collins JC, McFarland BH: Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008, 107(1-3):23-28.
49. Gibbons RD, Hur K, Brown CH, Mann JJ: Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009, 66(12):1354-1360.
50. Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, Burke AK, Harkavy-Friedman J, Sublette ME, Parsey RV, Mann JJ: Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry 2011, 168(10):1050-1056.
51. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010, 375(9712):385-395.
52. Kessing LV, Hansen HV, Hvenegaard A, Christensen EM, Dam H, Gluud C, Wetterslev J: Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry 2013, 202(3):212-219.
53. Colom F, Vieta E, Sanchez-Moreno J, Palomino-Otiniano R, Reinares M, Goikolea JM, Benabarre A, Martinez-Aran A: Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 2009, 194(3):260-265.
54. Lolich M, Vazquez GH, Alvarez LM, Tamayo JM: Psychosocial interventions in bipolar disorder: a review. Actas Esp Psiquiatr 2012, 40(2):84-92.
55. Goodwin GM: Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxf) 2009, 23(4):346-388.
56. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M: Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993, 50(6):448-455.
57. Baldessarini RJ, Tondo L, Faedda GL, Suppes TR, Floris G, Rudas N: Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry 1996, 57(10):441-448.
58. Johnson RE, McFarland BH: Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 1996, 153(8):993-1000.
59. Kessing LV, Sondergard L, Kvist K, Andersen PK: Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007, 9(7):730-736.